Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2022 | NK cells vs T-cells

Ulrike Koehl • 7 Feb 2022
CAR-T Meeting 2022
General CAR-T

Ulrike Koehl, MD, PhD, University of Leipzig, Leipzig, Germany, talks on the uses and advantages of natural killer (NK) cells over T-cells. This interview took place at the EBMT-EHA 4th European CAR T-cell Meeting which was held virtually in 2022.

Disclosures

Cooperation: Novartis, Miltenyi Biotec
Consulting: AstraZeneca, Affimed, Glycostem, GammaDelta, Zelluna

More from Ulrike Koehl

Scaling up CAR-T manufacturing with automation and digitalization
0:46
Scaling up CAR-T manufacturing with automation and digitalization
Ulrike Koehl • 7 Feb 2022
Minimizing the costs of CAR-T manufacturing
0:56
Minimizing the costs of CAR-T manufacturing
Ulrike Koehl • 7 Feb 2022
Centralized vs decentralized manufacturing of CAR-T therapies
0:49
Centralized vs decentralized manufacturing of CAR-T therapies
Ulrike Koehl • 7 Feb 2022
Optimizing NK cell manufacturing
1:14
Optimizing NK cell manufacturing
Ulrike Koehl • 7 Feb 2022

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI in clinical decision-making
2:25
Addressing the risk of over-reliance on AI in clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026
The content of VJHemOnc is intended for healthcare professionals